Terms: = Brain cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR
67 results:
1. Systematic review and cumulative analysis of clinical properties of BRAF V600E mutations in PLNTY histological samples.
Baumgartner ME; Lang SS; Tucker AM; Madsen PJ; Storm PB; Kennedy BC
Childs Nerv Syst; 2024 May; 40(5):1361-1366. PubMed ID: 38150037
[TBL] [Abstract] [Full Text] [Related]
2. Clinical significance of molecular subgroups of polymorphous low-grade neuroepithelial tumor of the young (PLNTY): A small single institutional case series and integrated analysis.
Vuong HG; Alzayadneh E; Reith TP; Eschbacher KL
Pathol Res Pract; 2023 Dec; 252():154922. PubMed ID: 37984047
[TBL] [Abstract] [Full Text] [Related]
3. Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin.
Liang WW; Lu RJ; Jayasinghe RG; Foltz SM; Porta-Pardo E; Geffen Y; Wendl MC; Lazcano R; Kolodziejczak I; Song Y; Govindan A; Demicco EG; Li X; Li Y; Sethuraman S; Payne SH; Fenyö D; Rodriguez H; Wiznerowicz M; Shen H; Mani DR; Rodland KD; Lazar AJ; Robles AI; Ding L;
Cancer Cell; 2023 Sep; 41(9):1567-1585.e7. PubMed ID: 37582362
[TBL] [Abstract] [Full Text] [Related]
4. Spatial distribution and functional relevance of FGFR1 and fgfr2 expression for glioblastoma tumor invasion.
Alshahrany N; Begum A; Siebzehnrubl D; Jimenez-Pascual A; Siebzehnrubl FA
Cancer Lett; 2023 Sep; 571():216349. PubMed ID: 37579831
[TBL] [Abstract] [Full Text] [Related]
5. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
[TBL] [Abstract] [Full Text] [Related]
6. Infiltrating gliomas with FGFR alterations: Histologic features, genetic alterations, and potential clinical implications.
Dono A; El Achi H; Bundrant BE; Goli PS; Zhu P; Ozkizilkaya HI; Esquenazi Y; Ballester LY
Cancer Biomark; 2023; 36(2):117-131. PubMed ID: 36530080
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Meta-analysis of Adipose Tissue Transcriptomics Data in PCOS Patients and Healthy Control Women.
Saedi S; Panahi R; Orak N; Jafarzadeh Shirazi MR
Reprod Sci; 2023 Jun; 30(6):1823-1833. PubMed ID: 36512189
[TBL] [Abstract] [Full Text] [Related]
8. Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood cancer.
Lazo De La Vega L; Comeau H; Sallan S; Al-Ibraheemi A; Gupta H; Li YY; Tsai HK; Kang W; Ward A; Church AJ; Kim A; Pinto NR; Macy ME; Maese LD; Sabnis AJ; Cherniack AD; Lindeman NI; Anderson ME; Cooney TM; Yeo KK; Reaman GH; DuBois SG; Collins NB; Johnson BE; Janeway KA; Forrest SJ
JCO Precis Oncol; 2022 Nov; 6():e2200390. PubMed ID: 36446043
[TBL] [Abstract] [Full Text] [Related]
9. [Clinicopathological features of polymorphous low-grade neuroepithelial tumor of the young].
Zhao S; Wang J; Li MN; Ding Y; Pan MH; Song K
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):640-646. PubMed ID: 35785835
[No Abstract] [Full Text] [Related]
10. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM
Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527
[TBL] [Abstract] [Full Text] [Related]
11. Genome-driven medicine for patients with recurrent glioma enrolled in early phase trials.
Baldini C; Younan N; Castanon Alvarez E; Ammari S; Alentorn A; Dumont S; Frenel JS; Di Stefano AL; Louvel G; Michot JM; Bahleda R; Postel-Vinay S; Varga A; Marabelle A; Hollebecque A; Bielle F; Hoang-Xuan K; Delattre JY; Dhermain F; Sanson M; Soria JC; Idbaih A; Massard C; Touat M
Eur J Cancer; 2022 Mar; 163():98-107. PubMed ID: 35063776
[TBL] [Abstract] [Full Text] [Related]
12. Neuroradiological features of the polymorphous low-grade neuroepithelial tumor of the young: five new cases with a systematic review of the literature.
Kurokawa M; Kurokawa R; Capizzano AA; Baba A; Ota Y; Pinarbasi E; Johnson T; Srinivasan A; Moritani T
Neuroradiology; 2022 Jun; 64(6):1255-1264. PubMed ID: 35001164
[TBL] [Abstract] [Full Text] [Related]
13. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
Dong L; Lu D; Chen R; Lin Y; Zhu H; Zhang Z; Cai S; Cui P; Song G; Rao D; Yi X; Wu Y; Song N; Liu F; Zou Y; Zhang S; Zhang X; Wang X; Qiu S; Zhou J; Wang S; Zhang X; Shi Y; Figeys D; Ding L; Wang P; Zhang B; Rodriguez H; Gao Q; Gao D; Zhou H; Fan J
Cancer Cell; 2022 Jan; 40(1):70-87.e15. PubMed ID: 34971568
[TBL] [Abstract] [Full Text] [Related]
14. Case of multifocal glioblastoma with four fusion transcripts of
Samii A; Sorokin M; Kar S; Makovskaia L; Garazha A; Hartmann C; Moisseev A; Kim E; Giese A; Buzdin A
Cold Spring Harb Mol Case Stud; 2021 Aug; 7(4):. PubMed ID: 34341009
[TBL] [Abstract] [Full Text] [Related]
15. Novel targetable fgfr2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs.
Georgescu MM; Islam MZ; Li Y; Traylor J; Nanda A
Acta Neuropathol Commun; 2021 Apr; 9(1):69. PubMed ID: 33853673
[TBL] [Abstract] [Full Text] [Related]
16. Surgical treatment and prognosis of focal brainstem gliomas in children: A 7 year single center experience.
Sun T; Xu Y; Pan C; Liu Y; Tian Y; Li C; Di F; Zhang L
Medicine (Baltimore); 2020 Sep; 99(36):e22029. PubMed ID: 32899058
[TBL] [Abstract] [Full Text] [Related]
17. Diffuse midline glioma with novel, potentially targetable,
Zanazzi G; Liechty BL; Pendrick D; Krasnozhen-Ratush O; Snuderl M; Allen JC; Garvin JH; Mansukhani MM; Roth KA; Hsiao SJ
Cold Spring Harb Mol Case Stud; 2020 Oct; 6(5):. PubMed ID: 32839179
[TBL] [Abstract] [Full Text] [Related]
18. Development and validation of a nomogram for predicting survival of advanced breast cancer patients in China.
Lin S; Mo H; Li Y; Guan X; Chen Y; Wang Z; Yuan P; Wang J; Luo Y; Fan Y; Cai R; Li Q; Chen S; Zhang P; Li Q; Ma F; Xu B
Breast; 2020 Oct; 53():172-180. PubMed ID: 32836201
[TBL] [Abstract] [Full Text] [Related]
19. Global activation of oncogenic pathways underlies therapy resistance in diffuse midline glioma.
Georgescu MM; Islam MZ; Li Y; Circu ML; Traylor J; Notarianni CM; Kline CN; Burns DK
Acta Neuropathol Commun; 2020 Jul; 8(1):111. PubMed ID: 32680567
[TBL] [Abstract] [Full Text] [Related]
20. Phase I, first-in-human study of futibatinib, a highly selective, irreversible FGFR1-4 inhibitor in patients with advanced solid tumors.
Bahleda R; Meric-Bernstam F; Goyal L; Tran B; He Y; Yamamiya I; Benhadji KA; Matos I; Arkenau HT
Ann Oncol; 2020 Oct; 31(10):1405-1412. PubMed ID: 32622884
[TBL] [Abstract] [Full Text] [Related]
[Next]
